Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
Be
CAS Number:
Molecular Weight:
9.01
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12141501
MDL number:
assay
99%
form
wire
autoignition temp.
1198 °F
manufacturer/tradename
Goodfellow 656-613-63
resistivity
4.46 μΩ-cm, 20°C
L × diam.
0.05 m × 0.6 mm
bp
2970 °C (lit.)
mp
1278 °C (lit.)
density
1.85 g/mL at 25 °C (lit.)
SMILES string
[Be]
InChI
1S/Be
InChI key
ATBAMAFKBVZNFJ-UHFFFAOYSA-N
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
Still not finding the right product?
Explore all of our products under Beryllium
signalword
Danger
Hazard Classifications
Acute Tox. 3 Oral - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 1
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Martin Harper
Journal of environmental monitoring : JEM, 8(6), 598-604 (2006-06-13)
Standardized conventions governing the fractions of airborne particles that can penetrate the human head airways, the thoracic airways and the alveolar spaces have been internationally (although not universally) adopted. Several agencies involved in setting limit values for occupational exposure concentrations
Paolo Boffetta et al.
Critical reviews in toxicology, 42(2), 107-118 (2012-01-27)
There is controversy on whether occupational exposure to beryllium causes lung cancer. We conducted a systematic review of epidemiologic studies on cancer among workers exposed to beryllium, including a study of seven U.S. production plants which has been recently updated
Massimo Amicosante et al.
Clinical immunology (Orlando, Fla.), 121(2), 134-143 (2006-05-16)
Chronic beryllium disease (CBD) is a granulomatous lung disorder caused by beryllium exposure in the workplace and is characterized by the accumulation of beryllium-specific CD4(+) T cells. Depending on genetic susceptibility and the nature of the exposure, CBD occurs in
Global Trade Item Number
| SKU | GTIN |
|---|---|
| GF65661363-1EA | 04061825368511 |